We are live on
!
Find out more
IP
Intellectus Partners Portfolio holdings
AUM
$578M
1-Year Est. Return
49.48%
This Fund
S&P 500
This Quarter
Est. Return
+2.94%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$291M
AUM Growth
+$23.1M
(+8.6%)
Cap. Flow
+$269M
Cap. Flow
% of AUM
92.57%
Top 10 Holdings %
Top 10 Hldgs %
28.45%
Holding
666
New
45
Increased
120
Reduced
128
Closed
66
Avg Time Held Equity + Options
4
quarters
Top 10 Avg Time Held Equity + Options
3.6
quarters
Top 20 Avg Time Held Equity + Options
3.3
quarters
Avg Time Held Equity only
4
quarters
Top 10 Avg Time Held Equity only
3.6
quarters
Top 20 Avg Time Held Equity only
3.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$247M |
| 2 |
Baozun
BZUN
|
+$16.2M |
| 3 |
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
|
+$3.76M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$2.33M |
| 5 |
Varonis Systems
VRNS
|
+$2.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$3.88M |
| 2 |
Xunlei
XNET
|
+$3.74M |
| 3 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
+$1.27M |
| 4 |
Everpure Inc
P
|
+$1.11M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$844K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.14% |
| 2 | Technology | 17.01% |
| 3 | Consumer Discretionary | 13.56% |
| 4 | Communication Services | 12.87% |
| 5 | Healthcare | 10.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Baozun
BZUN
$202M
| $18.9M | 6.48% |
+411,000
| New | +$16.2M |
2018 Q1
0 quarters
|
|
2
Meta Platforms (Facebook)
META
$1.94T
| $17.1M | 5.88% |
107,528
+6,590
| +7% | +$1.18M |
2016 Q4
5 quarters
|
|
3
Apple
AAPL
$4.98T
| $9.98M | 3.43% |
237,840
-7,560
| -3% | -$325K |
2016 Q4
5 quarters
|
|
|
SRNE
4
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $6.97M | 2.4% |
1,354,448
-178,000
| -12% | -$1.27M |
2016 Q4
5 quarters
|
|
5
Amazon
AMZN
$2.79T
| $6.12M | 2.1% |
84,500
-11,280
| -12% | -$807K |
2016 Q4
5 quarters
|
|
6
Delta Air Lines
DAL
$52.3B
| $6.01M | 2.07% |
109,667
+3,646
| +3% | +$201K |
2016 Q4
5 quarters
|
|
7
Alphabet (Google) Class C
GOOG
$4.27T
| $4.9M | 1.68% |
94,900
-6,740
| -7% | -$372K |
2016 Q4
5 quarters
|
|
8
Microsoft
MSFT
$4.04T
| $4.89M | 1.68% |
53,596
-1,288
| -2% | -$118K |
2016 Q4
5 quarters
|
|
|
9
Xunlei
XNET
$319M
| $4.06M | 1.4% |
402,485
-260,500
| -39% | -$3.74M |
2017 Q4
1 quarter
|
|
10
IBM
IBM
$217B
| $3.91M | 1.34% |
26,650
-657
| -2% | -$99.4K |
2016 Q4
5 quarters
|
|
11
WisdomTree Japan Hedged Equity Fund
DXJ
$2.38B
| $3.81M | 1.31% |
204,342
+27,768
| +16% | +$539K |
2016 Q4
5 quarters
|
|
|
12
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.43B
| $3.75M | 1.29% |
+75,356
| New | +$3.76M |
2018 Q1
0 quarters
|
|
13
Baidu
BIDU
$28.5B
| $3.7M | 1.27% |
16,594
+5,317
| +47% | +$1.31M |
2017 Q2
3 quarters
|
|
14
Alphabet (Google) Class A
GOOGL
$4.33T
| $3.27M | 1.12% |
62,960
-3,860
| -6% | -$214K |
2016 Q4
5 quarters
|
|
15
iShares Biotechnology ETF
IBB
$10.2B
| $3.07M | 1.06% |
28,802
+1,245
| +5% | +$138K |
2016 Q4
5 quarters
|
|
16
JPMorgan Chase
JPM
$881B
| $3.01M | 1.03% |
27,389
+176
| +0.6% | +$19.9K |
2016 Q4
5 quarters
|
|
17
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.74B
| $2.91M | 1% |
92,842
+16,746
| +22% | +$535K |
2016 Q4
5 quarters
|
|
18
Goldman Sachs
GS
$260B
| $2.58M | 0.89% |
10,250
+500
| +5% | +$130K |
2016 Q4
5 quarters
|
|
19
PayPal
PYPL
$48.1B
| $2.55M | 0.88% |
33,585
-2,788
| -8% | -$221K |
2016 Q4
5 quarters
|
|
|
CELG
20
DELISTED
Celgene Corp
CELG
| $2.5M | 0.86% |
27,964
-3,676
| -12% | -$353K |
2016 Q4
5 quarters
|
|
21
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $2.47M | 0.85% |
9,353
-64
| -0.7% | -$17.5K |
2016 Q4
5 quarters
|
|
22
DoubleLine Income Solutions Fund
DSL
$1.14B
| $2.44M | 0.84% |
121,701
+54,890
| +82% | +$1.1M |
2016 Q4
5 quarters
|
|
|
AGN
23
DELISTED
Allergan plc
AGN
| $2.36M | 0.81% |
13,999
+1,244
| +10% | +$209K |
2016 Q4
5 quarters
|
|
|
24
Vanguard Short-Term Bond ETF
BSV
$45.4B
| $2.33M | 0.8% |
+29,657
| New | +$2.33M |
2018 Q1
0 quarters
|
|
25
Corcept Therapeutics
CORT
$12.7B
| $2.25M | 0.77% |
136,696
-2,250
| -2% | -$41.7K |
2016 Q4
5 quarters
|
|
Similar funds
AFGAS
RWM
AHL
CTAF
HIM
SSP
CA
PWM
Intellectus Partners's Q1 2018 Portfolio in Review
As of Q1 2018, Intellectus Partners held 666 positions worth $291M, up 8.6% from $268M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Intellectus Partners deployed $269M of net new capital in Q1 2018, opening 45 new positions and adding to 120 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 800 shares worth $102K.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Xunlei, an estimated $3.74M trimmed.
- Intellectus Partners's largest Q1 2018 buy was Berkshire Hathaway Class A: 800 shares worth $102K.
- Intellectus Partners added most to Baidu in Q1 2018, an estimated $1.31M increase.
- Intellectus Partners's biggest Q1 2018 reduction was Xunlei, cutting an estimated $3.74M.
- Intellectus Partners fully exited ASML in Q1 2018, selling an estimated $3.88M.
- Intellectus Partners's ten largest holdings make up 28% of its $291M portfolio in Q1 2018.
- Intellectus Partners opened 45 new positions and closed 66 in Q1 2018.
- Intellectus Partners's portfolio value rose 8.6% quarter-over-quarter to $291M.
Based on Intellectus Partners's 13F filing for Q1 2018, filed 15 May 2018.